Mersana Therapeutics to Host Third Quarter 2025 Conference Call on November 14, 2025
Mersana Therapeutics to Host Third Quarter 2025 Conference Call on November 14, 2025 GlobeNewswire November 10, 2025 CAMBRIDGE, Mass., Nov. 10, 2025 (GLOBE NEWSWIRE) — Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on the development of antibody-drug conjugates (ADCs) targeting cancers in areas of high unmet medical need, today announced that it […]